Coiled Therapeutics (COIL.L) traded flat 0 % during a 24 hours period ending at 04:47 PM Central Europe on Monday 26th. One Coiled Therapeutics stock can currently be bought for about GBX 6.8 on popular exchanges. Current supply of Coiled Therapeutics stocks is 4.3 mn. Coiled Therapeutics has a current market capitalization of GBX 40.7 mn and approximately GBX 2.5 mn worth of Coiled Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Coiled Therapeutics has traded -7.74 % down. Simple moving average of last 200 days is at GBX 9.4. The highest price of past 52 weeks was recorded at GBX 30 on 11/28/2025. 52 weeks low was at GBX 0.95 on 04/01/2026.
Here is how related stocks have performed in the past 24 hours:
Helium One Global (HE1.L) traded down -1.96 % and now trades at GBX 0.3. Current market capitalisation for Helium One Global is GBX 40.8 mn.
Pebble Beach (PEB.L) traded down -1.75 % and now trades at GBX 28.8. Current market capitalisation for Pebble Beach is GBX 47.4 mn. Pebble Beach has a current price to earnings ratio of 9.32.
Biodexa (BDRX) traded up 2.17 % and now trades at USD 3.44. Biodexa has a market capitalisation of USD 435.6 k.
Shoe Zone (SHOE.L) traded down -3.27 % and now trades at GBX 73. Current market capitalisation for Shoe Zone is GBX 45 mn.
Synectics (SNX.L) traded down -1.3 % and now trades at GBX 191.49. Synectics has a market capitalisation of GBX 43.2 mn. Synectics has a current price to earnings ratio of 45.24.
About Coiled Therapeutics
Roquefort Therapeutics PLC is a biotechnology company based in London, United Kingdom. The company specializes in developing RNA therapeutics drugs for the treatment of various health issues such as cancer, chronic inflammation, autoimmune disorders, and COVID-19. They serve both patients and healthcare professionals during the pre-clinical phase before partnering and selling to big pharma.